Package Insert: Information for the Patient
Paliperidone Teva 3 mg Extended-Release Tablets EFG
Paliperidone Teva 6 mg Extended-Release Tablets EFG
Paliperidone Teva 9 mg Extended-Release Tablets EFG
Read this package insert carefully before you start taking this medicine because it contains important information for you.
Contents of the package and additional information
Paliperidone Teva contains the active ingredient paliperidone, which belongs to the class of m e d ic amen t os a nt i ps ic ót ic os.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms that include hearing, seeing or feeling things that do not exist, having false beliefs, having an abnormal distrust, withdrawing into oneself, speaking incoherently and flattening of behavior and emotion. People with this disorder may also feel d e p r e s s e d , a n x i o u s , g u i l t y , or t e n s e .
Paliperidone is also used to treat schizoaffective disorder in adults.
Schizoaffective disorder is a mental condition in which the person experiences some of the symptoms of s c h i z o p h r e n i a ( l i s t e d in t h e p a r a g r a p h s a b o v e ) a s w e ll a s o n e o f t h e s y m p t o m s o f m a n i a c d e p r e s s i o n s ( s e n s a t i o n o f e u f o r i a , d e p r e s s i o n , a g i t a t i o n , d i s t r a c t e d , l a c k o f f f o c u s , o r o t h e r s p e n s a t i o n s o f s u i c i d e .
Paliperidone may help alleviate the symptoms of your illness and prevent it from recurring.
Do not takepaliperidone
-if you are allergic to paliperidone, risperidone, or any of the other ingredients in thismedicine(listed in section6).
Warnings andprecautions
Consult your doctor or pharmacist before starting to take paliperidone.
If you have any of these conditions, please consult your doctor as it may be necessary to adjust your dose or keep you under observation for a while.
Because, in very rare cases, a dangerously low number of a type of white blood cells necessary to fight infections in the blood has been observed in patients treated with paliperidone, your doctor may check the number of white blood cells in your blood.
Paliperidone may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
In patients treated with paliperidone, diabetes mellitus or worsening of existing diabetes mellitus has been observed. Your doctor should check for signs of increased blood sugar.In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During cataract surgery in the eye, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery and this may cause damage to the eye.Make sure to inform your ophthalmologist that you are taking thismedicinebefore undergoing eye surgery.
Children andadolescents
Paliperidone should not be administered to children and adolescents under 15 years old for the treatment ofschizophrenia.
Paliperidone should not be administered to children and adolescents under 18 years old for the treatment ofschizoaffectivedisorder.
This is because the safety and efficacy of paliperidone in this age group are unknown.
Othermedicines and paliperidone
Inform your doctor or pharmacist if you are using, have used recently, or may take othermedicaments.
Abnormalities in heart function may occur when this medication is taken with other medications for heart rhythm control or other medications such as antihistamines, antimalarials, orantipsicótics.
Since this medication primarily acts on the brain, this medication may interfere with other medications (or alcohol) that also act on it, due to the sum of effects onbrainfunctioncerebral.
This medication may lower blood pressure, so you should be careful if you take this medication with other medications that also lowerbloodpressure.
This medication may reduce the effect of medications for Parkinson's disease and restless legs syndrome (e.g.,levodopa).
The effects of this medication may be affected if you take medications that influence the speed of intestinal movement (e.g.,metoclopramida).
Consider reducing the dose of this medication when it is administered withvalproato.
It is not recommended to use oral risperidone with this medication as thiscombinationmayprovokeanincedeffectsadverses.
Paliperidone should be used with caution with medications that increase the activity of the central nervous system (psycho-stimulants such as metilphenidato).
Paliperidone and alcohol
You should avoid consuming alcohol during treatment with thismedicine.
Pregnancy andlactation
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before taking thismedicine.
You should not take this medication during pregnancy unless you have discussed it with your doctor.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last trimester of pregnancy (last three months of pregnancy): tremor, rigidity, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
You should not breastfeed your baby while taking this medication.
Driving and use ofmachinery
During treatment with this medication, dizziness and vision problems may occur (see section 4, Possible side effects). This should be taken into account when requiring maximum attention, for example, when driving or operatingmachinery.
Paliperidone Teva contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet, which may be considered as “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist.médico or pharmacist..In case of doubt, consult your doctor or pharmacist again.
Use in adultsadultos
The recommended dose in adults is 6 mg once a day in the morning. Your doctor may increase or decrease it within the dosing interval of 3 mg to 12 mg once a day in case of schizophrenia or 6 mg to 12 mg once a day in case of schizoaffective disorder. This depends on how well the medication works for you.
Use in adolescents and childrencentes
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years or older is 3 mg once a day taken in the morning.
For adolescents weighing 51 kg or more, the dose can be increased within the interval of 6 mg to 12 mg once a day.
For adolescents weighing less than 51 kg, the dose can be increased to 6 mg once a day.
Your doctor will decide how much to administer to you. The amount you take depends on how well the medication works for you.
How and when to take paliperidone
This medication should be taken orally, swallowed whole with water or other liquids. It cannot be chewed, divided, or crushed.
This medication should be taken in the mornings with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication with breakfast and on an empty stomach the next day.
The active ingredient, paliperidone, dissolves once swallowed, and the coating of the tablet is eliminated by the body through the intestines.
Patients with kidney problems
Your doctor may adjust the dose of this medication according to your kidney function.
Patients of advanced age
Your doctor may reduce your medication dose if your kidney function is reduced.
If you take more paliperidone than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicological Information Service. Phone: 91 562 04 20 indicating the medication and the amount ingested. You may experience drowsiness, dizziness, abnormal body movements, difficulty staying upright and walking, dizziness due to reduced blood pressure, and cardiac rhythm alterations.
If you forgot to take paliperidone
Do not take a double dose to compensate for the missed doses. If you forget a dose, take the next dose the next day. If you forget two or more doses, contact your doctor.
If you interrupt the treatment with paliperidone
Do not stop taking this medication as you will lose the effects of the medication. Do not stop taking this medication unless your doctor tells you to, as the symptoms may reappear.
If you have any other doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following:
• Blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which can travel through the blood vessels to the lungs, causing chest pain and difficulty breathing. If you experience any of these symptoms, seek medical advice.
• Dementia and a sudden change in your mental state or sudden weakness or numbness in the face, arms, or legs, especially on one side, or difficulty speaking even for a short period of time. These may be signs of a heart attack.
• Fever, muscle stiffness, sweating, or a decrease in consciousness (a condition known as "Neuroleptic Malignant Syndrome"). You may need medical treatment.
• Men: prolonged or painful erection (priapism). You may need medical treatment.
• Uncontrollable movements of the tongue, mouth, or face. You may need to stop taking this medicine.
• Severe allergic reaction, characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, hives, and sometimes a decrease in blood pressure (anaphylactic reaction).
Very common (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Unknown (frequency cannot be estimated from available data):
The following side effects have appeared with the use of another medication called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone:
Other types of blood vessel problems in the brain, crackling sounds from the lungs, severe or potentially life-threatening skin rash with blisters and peeling of the skin that may start in the mouth, nose, eyes, and genitals and spread to other areas of the body (Stevens-Johnson syndrome/toxic epidermal necrolysis). Eye problems may also occur during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your eye surgeon if you are taking or have taken this medication.
Additional side effects in adolescents:
Adolescents generally experienced side effects similar to those found in adults, except for the following side effects that were detected more frequently:
Reporting of side effects:
If you experience side effects, consult your doctor, pharmacist, or nurse, even if the side effects do not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and blister after CAD or EXP. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not require special temperature conditions for its conservation.
Medicines should not be thrown down the drains or in the trash. Dispose of the containers and medicines you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Paliperidone Teva
Appearance of the product and contents of the package
3 mg: Prolonged-release tablets coated with a red film, biconvex, white to light gray, with possible uneven surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9mm.
6 mg: Prolonged-release tablets coated with a red film, biconvex, yellowish-brown, with possible uneven surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9mm.
9 mg: Prolonged-release tablets coated with a red film, biconvex, light pink, with possible uneven surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9mm.
Paliperidone Teva is available in boxes containing:
Not all package sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Teva B.V.
Swensweg 5
Haarlem 2031GA
Netherlands
Responsible for manufacturing:
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501
Slovenia
O
Laboratoria Qualiphar NV (Qualiphar NV)
Rijksweg 9
2880 Bornem
Belgium
For more information about this medicine, please contact the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
c/ Anabel Segura 11, Edificio Albatros B, 1ª planta, Alcobendas,
28108 Madrid (Spain)
Last review date of thisleaflet:November 2024
More detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.